Cargando…
Cerebral hemodynamics and endothelial function in patients with Fabry disease
BACKGROUND: Cerebral vasculopathy have been described in Fabry disease, in which altered cerebral blood flow, vascular remodelling or impairment of endothelial function could be involved. Our study aims to evaluate these three possibilities in a group of Fabry patients, and compare it to healthy con...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828577/ https://www.ncbi.nlm.nih.gov/pubmed/24207059 http://dx.doi.org/10.1186/1471-2377-13-170 |
_version_ | 1782291263664422912 |
---|---|
author | Segura, Tomás Ayo-Martín, Oscar Gómez-Fernandez, Isabel Andrés, Carolina Barba, Miguel A Vivancos, José |
author_facet | Segura, Tomás Ayo-Martín, Oscar Gómez-Fernandez, Isabel Andrés, Carolina Barba, Miguel A Vivancos, José |
author_sort | Segura, Tomás |
collection | PubMed |
description | BACKGROUND: Cerebral vasculopathy have been described in Fabry disease, in which altered cerebral blood flow, vascular remodelling or impairment of endothelial function could be involved. Our study aims to evaluate these three possibilities in a group of Fabry patients, and compare it to healthy controls. METHODS: Cerebral hemodynamics, vascular remodelling and systemic endothelial function were investigated in 10 Fabry patients and compared to data from 17 healthy controls. Transcranial Doppler was used to study blood flow velocity of intracranial arteries and cerebral vasomotor reactivity. For the study of vascular remodelling and endothelial function, intima-media thickness of common carotid arteries, flow-mediated dilation in brachial artery and serum levels of soluble VCAM-1, TNF-α, high-sensitive CRP and IL-6 were measured. Differences between groups were evaluated using appropriate tests. RESULTS: No relevant differences were observed in cerebral hemodynamic parameters, intima-media thickness or flow-mediated dilation. There was a trend for low serum levels of IL-6 and high serum levels of TNF-α and high-sensitive CRP in Fabry patients; plasma concentrations of soluble VCAM-1 were significantly higher in Fabry disease patients than in healthy volunteers (p = 0.02). CONCLUSIONS: In our sample, we did not find relevant alterations of cerebral hemodynamics in Fabry disease patients. Increased levels of plasmatic endothelial biomarkers seem to be the most important feature indicative of possible vascular dysfunction in Fabry disease patients. |
format | Online Article Text |
id | pubmed-3828577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38285772013-11-16 Cerebral hemodynamics and endothelial function in patients with Fabry disease Segura, Tomás Ayo-Martín, Oscar Gómez-Fernandez, Isabel Andrés, Carolina Barba, Miguel A Vivancos, José BMC Neurol Research Article BACKGROUND: Cerebral vasculopathy have been described in Fabry disease, in which altered cerebral blood flow, vascular remodelling or impairment of endothelial function could be involved. Our study aims to evaluate these three possibilities in a group of Fabry patients, and compare it to healthy controls. METHODS: Cerebral hemodynamics, vascular remodelling and systemic endothelial function were investigated in 10 Fabry patients and compared to data from 17 healthy controls. Transcranial Doppler was used to study blood flow velocity of intracranial arteries and cerebral vasomotor reactivity. For the study of vascular remodelling and endothelial function, intima-media thickness of common carotid arteries, flow-mediated dilation in brachial artery and serum levels of soluble VCAM-1, TNF-α, high-sensitive CRP and IL-6 were measured. Differences between groups were evaluated using appropriate tests. RESULTS: No relevant differences were observed in cerebral hemodynamic parameters, intima-media thickness or flow-mediated dilation. There was a trend for low serum levels of IL-6 and high serum levels of TNF-α and high-sensitive CRP in Fabry patients; plasma concentrations of soluble VCAM-1 were significantly higher in Fabry disease patients than in healthy volunteers (p = 0.02). CONCLUSIONS: In our sample, we did not find relevant alterations of cerebral hemodynamics in Fabry disease patients. Increased levels of plasmatic endothelial biomarkers seem to be the most important feature indicative of possible vascular dysfunction in Fabry disease patients. BioMed Central 2013-11-11 /pmc/articles/PMC3828577/ /pubmed/24207059 http://dx.doi.org/10.1186/1471-2377-13-170 Text en Copyright © 2013 Segura et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Segura, Tomás Ayo-Martín, Oscar Gómez-Fernandez, Isabel Andrés, Carolina Barba, Miguel A Vivancos, José Cerebral hemodynamics and endothelial function in patients with Fabry disease |
title | Cerebral hemodynamics and endothelial function in patients with Fabry disease |
title_full | Cerebral hemodynamics and endothelial function in patients with Fabry disease |
title_fullStr | Cerebral hemodynamics and endothelial function in patients with Fabry disease |
title_full_unstemmed | Cerebral hemodynamics and endothelial function in patients with Fabry disease |
title_short | Cerebral hemodynamics and endothelial function in patients with Fabry disease |
title_sort | cerebral hemodynamics and endothelial function in patients with fabry disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828577/ https://www.ncbi.nlm.nih.gov/pubmed/24207059 http://dx.doi.org/10.1186/1471-2377-13-170 |
work_keys_str_mv | AT seguratomas cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease AT ayomartinoscar cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease AT gomezfernandezisabel cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease AT andrescarolina cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease AT barbamiguela cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease AT vivancosjose cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease |